Noteworthy Rating Filing: Scisys (LON:SSY) “Corporate” Rating Reaffirmed by FinnCap; With GBX 155.00 Target

November 25, 2016 - By Richard Conner

Scisys (LON:SSY) Rating

In an analyst note revealed to clients and investors on Friday, 25 November, Scisys (LON:SSY) stock had its “Corporate” Rating reiterated by professional analysts at FinnCap. They currently have a GBX 155.00 target price on company. FinnCap’s target means a potential upside of 39.64% from the company’s previous stock close.

The stock decreased 0.45% or GBX 0.5 on November 25, hitting GBX 110.5. About 51,604 shares traded hands or 86.46% up from the average. Scisys Plc (LON:SSY) has risen 59.71% since April 28, 2016 and is uptrending. It has outperformed by 54.30% the S&P500.

Analysts await SunLink Health Systems, Inc. (NYSEMKT:SSY) to report earnings on February, 21.

Insitutional Activity: The institutional sentiment increased to 3 in Q2 2016. Its up 3.00, from 0 in 2016Q1. The ratio is positive, as 4 funds sold all Scisys Plc shares owned while 1 reduced positions. 0 funds bought stakes while 0 increased positions. They now own 252,999 shares or 44.58% less from 456,473 shares in 2016Q1.

California Employees Retirement accumulated 25,182 shares or 0% of the stock. Wells Fargo And Company Mn, a California-based fund reported 453 shares. Blackrock Institutional Trust Company Na, a California-based fund reported 1 shares. Bancshares Of New York Mellon accumulated 10,693 shares or 0% of the stock. State Street accumulated 10,300 shares or 0% of the stock. Vanguard Grp has invested 0% of its portfolio in Scisys Plc (LON:SSY). Earnest Partners Ltd Liability last reported 0% of its portfolio in the stock. Creative Planning holds 7,500 shares or 0% of its portfolio. Acadian Asset Management Ltd Liability Co has invested 0% of its portfolio in Scisys Plc (LON:SSY). Geode Capital Ltd Com owns 19,190 shares or 0% of their US portfolio. Renaissance Limited Liability Company holds 0% of its portfolio in Scisys Plc (LON:SSY) for 54,700 shares. Manufacturers Life Insurance Company The last reported 0% of its portfolio in the stock. Fifth Third National Bank has 0% invested in the company for 42 shares. Granite Invest Ptnrs Lc owns 50,147 shares or 0% of their US portfolio.

SCISYS PLC is a United Kingdom-based company, which is engaged in developing information technology services. The company has a market cap of 32.26 million GBP. The Firm develops application solutions and products, and provides supporting services. It has a 13.69 P/E ratio. The Firm provides IT services to firms and public sector organizations through four divisions: Space; Enterprise Solutions & Defence (ESD); Media & Broadcast (M&B), and Xibis Ltd.

According to Zacks Investment Research, “SunLink Health Systems, Inc. operates two business segments, the United States community hospital segment and the United Kingdom housewares segment. The U.S. community hospital segment is comprised of community hospitals and related businesses in the U.S., which are operated through its subsidiary, SunLink Healthcare Corp. The United Kingdom housewares segment manufactures and distributes, through its Beldray Limited subsidiary, housewares products in the United Kingdom.”

SSY Company Profile

SunLink Health Systems, Inc., incorporated on June 9, 1959, through its subsidiaries, owns businesses, which provide healthcare services in various markets in the United States. The Company’s divisions include Healthcare Facilities, Specialty Pharmacy, and Corporate and Other. The Company’s Specialty Pharmacy segment is operated through its subsidiary, SunLink ScriptsRx, LLC (Scripts). As of June 30, 2016, its Healthcare Facilities segment subsidiaries owned and operated a 84 bed community hospital and a 66 bed nursing home in Mississippi, and a 100 bed nursing home in Georgia. As of June 30, 2016, the Specialty Pharmacy Segment subsidiary operated a specialty pharmacy business in Louisiana with four service lines.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>